Charles River Laboratories: Price Discovery

Summary

  • Charles River has seen a bit slower growth this year, accompanied by modest margin pressure.
  • Shares sold off too much over the past summer, which created an excellent long-term entry point.
  • After a quick and strong recovery in recent weeks, I am in doubt whether to take profits or hold on to this excellent long-term investment.
  • Looking for a portfolio of ideas like this one? Members of Value In Corporate Events get exclusive access to our subscriber-only portfolios. Learn More »

Empty science laboratory

Solskin

Shares of Charles River Laboratories (NYSE:CRL) have been tumbling amidst concerns about slower growth, margin pressure, and higher interest rates. Consequently, shares have been cut in half from a peak above $450 per share in September last year, now settling at $242 per share after recently

If you like to see more ideas, please subscribe to the premium service "Value in Corporate Events" here and try the free trial. In this service we cover major earnings events, M&A, IPOs and other significant corporate events with actionable ideas. Furthermore, we provide coverage of situations and names on request!

This article was written by

The Value Investor profile picture
22.87K Followers
Finding value that gets unlocked in M&A, IPOs and other corporate events
The writer is a long term value investor and M.Sc graduate in Financial Markets with over 10 years experience. Value can be found in both long and short ideas and uses options to enhance the risk-return profile of investment ideas. Disclaimer: This article provides opinions and information, but does not contain recommendations or personal investment advice to any specific person for any particular purpose. Do your own research or obtain suitable personal advice.

Disclosure: I/we have a beneficial long position in the shares of CRL either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.